Skip to content

Clinical effect of dezocine combined with dexmedetomidine in inhibiting hyperalgesia after remifentanil anesthesia: a randomized controlled trial.

Clinical effect of dezocine combined with dexmedetomidine in inhibiting hyperalgesia after remifentanil anesthesia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034774
Enrollment
Unknown
Registered
2020-07-18
Start date
2020-07-20
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperpathia

Interventions

Groups A:Normal saline (1 g/kg) was pumped within 10min before induction of anesthesia, followed by continuous pumping (0.5 g/kg/h) until 30min before the end of surgery. Dezocine was administrated or
Groups B:DEX (1 g/kg) was pumped within 10min before induction of anesthesia, and 0.5 g/kg/h was continuously pumped until 30min before the end of surgery. The same volume of normal saline was injecte
Groups AB:DEX (1 g/kg) was pumped within 10min before induction of anesthesia, 0.5 g/kg/h was continuously pumped after completion until 30min before the end of surgery, and dezocine was administrated
Groups C:Normal saline (1 g/kg) was pumped within 10min before induction of anesthesia, and continued to be pumped (0.5 g/kg/h) until 30min before the end of surgery. The same volume of normal saline

Sponsors

Department of Anesthesiology, Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to our hospital for gynecological laparoscopic surgery under general anesthesia; 2. ASA grade I-II; 3. Aged 20-60 years; 4. BMI 18-29 kg/m2; 5. Operation time is more than 1 hour; 6. Patients or their family members sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to the test drugs or have other contraindications; 2. Serious diseases of the heart, brain, liver, kidney, lung and endocrine system; 3. A history of mental disorder, chronic pain or pain paresthesia; 4. A recent history of pain including surgery and trauma; 5. Patients who take sedatives and analgesics for a long time or rely on sedatives and analgesics; 6. Alcoholism patients; 7. Patients with cognitive dysfunction; 8. Pregnant and lactating women; 9. Participated in additional clinical studies in the past 30 days.

Design outcomes

Primary

MeasureTime frame
Pain threshold;

Secondary

MeasureTime frame
NRS score, Ramsay score, BCS score;Postoperative analgesic drug addition, postoperative analgesic pump effective times;

Countries

China

Contacts

Public ContactZhang Pengbo

The Second Affiliated Hospital of Xi'an Jiaotong University

zhpbo@163.com+86 13759891076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026